Alterations of erythrocyte ATPase activity and oxygen consumption in patients with liver-blood deficiency syndrome

Table 1 General clinical data

	n	Male/Female	Age (yr)	Diseases
Control group	30	15/15	34.2 ± 10.4 (20-46)
Erythrocyte membrane ATPase	31	11/20	36.6 ± 13.6 (19-56)	IDA 16, CAA 15
Erythrocyte OCR	35	13/22	35.8 ± 15.2 (21-48)	IDA 19, CAA 16

Table 2 Comparison of ATPase activities

Groups	n	Mg2+-ATPase	Na+-K+-ATPase	Ca2+-ATPase
			(µmol Pi·mg protein·h)
Control	30	0.300 ± 0.160	0.250 ± 0.120	0.620 ± 0.170
LBDS	31	0.130 ± 0.072b	0.154 ± 0.081b	0.530 ± 0.159a
CAA	15	0.132 ± 0.044b	0.156 ± 0.067b	0.562 ± 0.130
IDA	16	0.132 ± 0.091b	0.152 ± 0.093b	0.468 ± 0.215a

^aP < 0.05,

^bP < 0.01 vs control.

Table 3 Comparison of erythrocyte OCR (oxygen consumption rate)

Groups	n	Oxygen consumption rate (µL 100·h·mL compressed RBC)
Control	30	107.26 ± 18.46
LBDS	35	82.25 ± 36.39b
CAA	16	68.83 ± 24.83b
IDA	19	100.17 ± 13.86a

^aP < 0.05 vs CAA,

^bP < 0.01 vs control.